Skip to main content

Association of resveratrol with the suppression of TNF-α/NF-kB/iNOS/HIF-1α axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury

Abstract 

Chronic liver injury can lead to hepatic failure and the only available method of treatment would be liver transplantation. The link between inflammation (TNF-α), nuclear factor-kappa B (NF-kB), nitrosative stress (iNOS) and hypoxia-inducible factor-1α (HIF-1α) in thioacetamide (TAA) induced liver fibrosis, and hypertension with and without the incorporation of the anti-inflammatory and antioxidant resveratrol (RES) has not been investigated before. Consequently, we injected rats with either 200 mg/kg TAA for 8 weeks starting at week 2 (model group) or pretreated them before TAA injections with RES (20 mg/kg) for 2 weeks and continued them on RES and TAA until being culled at week 10 (protective group). In the model group, we documented the induction of hepatic fibrosis and upregulation of tumor necrosis factor-α (TNF-α), NF-kB, inducible nitric oxide synthase (iNOS), HIF-1α and the profibrotic biomarkers alpha-smooth muscle actin (α-SMA) and matrix metalloproteinase-9 (MMP-9) that was significantly (p ≤ 0.0014) ameliorated by RES. RES also significantly (p ≤ 0.0232) reduced triglycerides (TG), cholesterol (CHOL), very low-density lipoprotein (vLDL-C), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure, and heart rate (HR) induction by TAA. Also, a significant (p < 0.0001) positive correlation between TNF-α/NF-kB/iNOS/HIF-1α axis-mediated fibrosis and hypertension and liver injury biomarkers was observed. These findings suggest that in the hepatotoxic compound, TAA is associated with TNF-α/NF-kB/iNOS/HIF-1α-mediated fibrosis and hypertension, whilst being inhibited by RES.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Data availability

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to confidential handling of our materials because this manuscript data is part of a big project which is underway.

References 

  • Al-Ani B (2013) Resveratrol inhibits proteinase-activated receptor-2-induced release of soluble vascular endothelial growth factor receptor-1 from human endothelial cells. Excli J 12:598–604

    PubMed  PubMed Central  Google Scholar 

  • Al-Ani B, Hewett PW, Cudmore MJ, Fujisawa T, Saifeddine M, Williams H, Ramma W, Sissaoui S, Jayaraman PS, Ohba M, Ahmad S, Hollenberg MD, Ahmed A (2010) Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells. Hypertension 55:689–697

    CAS  Article  Google Scholar 

  • Al-Ani B, Alzamil NM, Hewett PW, Al-Hashem F, Bin-Jaliah I (2021) Metformin ameliorates ROS-p53-collagen axis of fibrosis and dyslipidemia in type 2 diabetes mellitus-induced left ventricular injury. Arch Physiol Biochem 1–7

  • Al-Attar AM, Shawush NA (2014) Physiological investigations on the effect of olive and rosemary leaves extracts in male rats exposed to thioacetamide. Saudi J Biol Sci 21:473–480

    CAS  Article  Google Scholar 

  • Alayev A, Sun Y, Snyder RB, Berger SM, YU, J. J. & Holz, M. K. (2014) Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells. Cell Cycle 13:371–382

    CAS  Article  Google Scholar 

  • Al-Hashem F, Al-Humayed S, Amin SN, Kamar SS, Mansy SS, Hassan S, Abdel-Salam LO, Abd Ellatif M, Alfaifi M, Haidara MA, Al-Ani B (2019) Metformin inhibits mTOR-HIF-1alpha axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations. J Cell Physiol 234:9328–9337

    CAS  Article  Google Scholar 

  • Anavi S, Eisenberg-Bord M, Hahn-Obercyger M, Genin O, Pines M, Tirosh O (2015) The role of iNOS in cholesterol-induced liver fibrosis. Lab Invest 95:914–924

    CAS  Article  Google Scholar 

  • Ball MK, Waypa GB, Mungai PT, Nielsen JM, Czech L, Dudley VJ, Beussink L, Dettman RW, Berkelhamer SK, Steinhorn RH, Shah SJ, Schumacker PT (2014) Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α. Am J Respir Crit Care Med 189:314–324

    Article  Google Scholar 

  • Boll M, Weber LW, Becker E, Stampfl A (2001) Pathogenesis of carbon tetrachloride-induced hepatocyte injury bioactivation of CCI4 by cytochrome P450 and effects on lipid homeostasis. Z Naturforsch C J Biosci 56:111–121

    CAS  Article  Google Scholar 

  • Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A, Berloco P, Rossi M, Attili AF, Gaudio E (2005) Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis 37:349–356

    CAS  Article  Google Scholar 

  • Chen C, Zou LX, Lin QY, Yan X, Bi HL, Xie X, Wang S, Wang QS, Zhang YL, LI, H. H. (2019) Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload. Redox Biol 20:390–401

    CAS  Article  Google Scholar 

  • Cudmore MJ, Ramma W, Cai M, Fujisawa T, Ahmad S, Al-Ani B, Ahmed A (2012) Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta. Am J Obstet Gynecol 206:25

    Article  Google Scholar 

  • Czaja AJ (2014) Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol 20:2515–2532

    CAS  Article  Google Scholar 

  • De Minicis S, Marzioni M, Benedetti A, Svegliati-Baroni G (2013) New insights in hepatocellular carcinoma: from bench to bedside. Ann Transl Med 1:2305–5839

    Google Scholar 

  • El-Sheikh AA, Morsy MA, Okasha AM (2017) Inhibition of NF-κB/TNF-α pathway may be involved in the protective effect of resveratrol against cyclophosphamide-induced multi-organ toxicity. Immunopharmacol Immunotoxicol 39:180–187

    CAS  Article  Google Scholar 

  • Friedman SL (2003) Liver fibrosis – from bench to bedside. J Hepatol 38:S38-53

    Article  Google Scholar 

  • Godichaud S, Krisa S, Couronné B, Dubuisson L, Mérillon JM, Desmoulière A, Rosenbaum J (2000) Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology 31:922–931

    CAS  Article  Google Scholar 

  • Gressner AM, Weiskirchen R (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 10:76–99

    CAS  Article  Google Scholar 

  • Gweon EJ, Kim SJ (2014) Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways. Oncol Rep 32:71–78

    CAS  Article  Google Scholar 

  • Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM (2006) Dyslipidemia and the risk of incident hypertension in men. Hypertension 47:45–50

    CAS  Article  Google Scholar 

  • Huang TC, Lu KT, Wo YY, Wu YJ, Yang YL (2011) Resveratrol protects rats from Aβ-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS ONE 6:e29102

    CAS  Article  Google Scholar 

  • Iwakiri Y (2015) Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase. Clin Mol Hepatol 21:319–325

    Article  Google Scholar 

  • Kawada N, Seki S, Inoue M, Kuroki T (1998) Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 27:1265–1274

    CAS  Article  Google Scholar 

  • Kessoku T, Imajo K, Honda Y, Kato T, Ogawa Y, Tomeno W, Kato S, Mawatari H, Fujita K, Yoneda M, Nagashima Y, Saito S, Wada K, Nakajima A (2016) Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis. Sci Rep 6:22251

    CAS  Article  Google Scholar 

  • Li TH, Lee PC, Lee KC, Hsieh YC, Tsai CY, Yang YY, Huang SF, Tsai TH, Hsieh SL, Hou MC, Lin HC, Lee SD (2016) Down-regulation of common NFκB-iNOS pathway by chronic thalidomide treatment improves hepatopulmonary syndrome and muscle wasting in rats with biliary cirrhosis. Sci Rep 6:39405

    CAS  Article  Google Scholar 

  • Lin YL, Lin HW, Chen YC, Yang DJ, Li CC, Chang YY (2017) Hepatoprotective effects of naturally fermented noni juice against thioacetamide-induced liver fibrosis in rats. J Chin Med Assoc 80:212–221

    Article  Google Scholar 

  • Luedde T, Schwabe RF (2011) NF-κB in the liver–linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 8:108–118

    CAS  Article  Google Scholar 

  • Madrigal JL, Hurtado O, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, Boscá L, Leza JC (2002) The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 26:155–163

    CAS  Article  Google Scholar 

  • Murthy S, Ryan A, He C, Mallampalli RK, Carter AB (2010) Rac1-mediated mitochondrial H2O2 generation regulates MMP-9 gene expression in macrophages via inhibition of SP-1 and AP-1. J Biol Chem 285:25062–25073

    CAS  Article  Google Scholar 

  • Neff GW, Duncan CW, Schiff ER (2011) The current economic burden of cirrhosis. Gastroenterol Hepatol (n y) 7:661–671

    Google Scholar 

  • Prysyazhna O, Wolhuter K, Switzer C, Santos C, Yang X, Lynham S, Shah AM, Eaton P, Burgoyne JR (2019) Blood pressure-lowering by the antioxidant resveratrol is counterintuitively mediated by oxidation of cGMP-dependent protein kinase. Circulation 140:126–137

    CAS  Article  Google Scholar 

  • Reif S, Aeed H, Shilo Y, Reich R, Kloog Y, Kweon YO, Bruck R (2004) Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid. J Hepatol 41:235–241

    CAS  Article  Google Scholar 

  • Robert S, Gicquel T, Bodin A, Lagente V & Boichot E (2016) Characterization of the MMP/TIMP imbalance and collagen production induced by IL-1beta or TNF-alpha release from human hepatic stellate cells. PLoS One 11:e0153118

  • Roth KJ, Copple BL (2015) Role of hypoxia-inducible factors in the development of liver fibrosis. Cell Mol Gastroenterol Hepatol 1:589–597

    Article  Google Scholar 

  • Srivani G, Behera SK, Dariya B, Aliya S, Alam A, Nagaraju GP (2020) Resveratrol binds and inhibits transcription factor HIF-1α in pancreatic cancer. Exp Cell Res 394:112126

    CAS  Article  Google Scholar 

  • Takeda N, O’Dea EL, Doedens A, Kim JW, Weidemann A, Stockmann C, Asagiri M, Simon MC, Hoffmann A, Johnson RS (2010) Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes Dev 24:491–501

    CAS  Article  Google Scholar 

  • Trepiana J, Milton-Laskibar I, Gomez-Zorita S, Eseberri I, Gonzalez M, Fernandez-Quintela A, Portillo MP (2018) Involvement of 5′-activated protein kinase (AMPK) in the effects of resveratrol on liver steatosis. Int J Mol Sci 19:3473

  • Tsai MY, Yang WC, Lin CF, Wang CM, Liu HY, Lin CS, Lin JW, Lin WL, Lin TC, Fan PS, Hung KH, Lu YW, Chang GR (2021) The Ameliorative Effects of Fucoidan in Thioacetaide-Induced Liver Injury in Mice. Molecules 26:1937

    CAS  Article  Google Scholar 

  • Wallace MC, Hamesch K, Lunova M, Kim Y, Weiskirchen R, Strnad P, Friedman SL (2015) Standard operating procedures in experimental liver research: thioacetamide model in mice and rats. Lab Anim 49:21–29

    CAS  Article  Google Scholar 

  • Yu B, Qin SY, Hu BL, Qin QY, Jiang HX, Luo W (2019) Resveratrol improves CCL4-induced liver fibrosis in mouse by upregulating endogenous IL-10 to reprogramme macrophages phenotype from M(LPS) to M(IL-4). Biomed Pharmacother 117:109110

    CAS  Article  Google Scholar 

  • Zhao Y, Tang H, Zeng X, Ye D, Liu J (2018) Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells. Biomed Pharmacother 98:36–44

    CAS  Article  Google Scholar 

  • Zhao Y, Ma X, Wang J, Zhu Y, Li R, Wang J, He X, Shan L, Wang R, Wang L, Li Y, Xiao X (2014) Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1alpha through mTOR-dependent pathway. Fitoterapia 99:318–327

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We are grateful to Dr Mariam Al-Ani from Face Studio Clinic, 90 Hagley Road, Edgbaston, Birmingham, B16 8LU, UK, for proofreading the manuscript.

Funding

This work was funded by the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University, through the Research Funding Program (Grant No# FRP – 1442—5).

Author information

Authors and Affiliations

Authors

Contributions

Conceived and designed the experiments: B. A.-A. and A. F. D.; performed the experiments: H. A. E., S. S. K., N. S. A. L., A. M. S. and M. A. E.; analyzed the data: H. A. E., M. D., M. A. H., A. F. D. and B. A.-A.; wrote the manuscript: B. A.-A., A. F. D. and H. A. E. The authors declare that all data were generated in-house and that no paper mill was used.

Corresponding author

Correspondence to Amal F. Dawood.

Ethics declarations

Ethical approval

Institutional review board, PNU, KSA no H-1-R-095.

Consent to participate and consent to publish

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (XLSX 17 KB)

Supplementary file2 (DOCX 1358 KB)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ebrahim, H.A., Kamar, S.S., Haidara, M.A. et al. Association of resveratrol with the suppression of TNF-α/NF-kB/iNOS/HIF-1α axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury. Naunyn-Schmiedeberg's Arch Pharmacol (2022). https://doi.org/10.1007/s00210-022-02264-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00210-022-02264-w

Keywords

  • Thioacetamide
  • Liver fibrosis
  • Hypertension
  • Rat model
  • Resveratrol
  • TNF-α/NF-kB/iNOS/HIF-1α axis